| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $322.2M | -47.7% |
| R&D Expense | $13.6M | +17.0% |
| SG&A Expense | $133.4M | -3.8% |
| Operating Income | -$178.0M | -720.6% |
| Pre-tax Income | -$187.5M | -775.7% |
| Income Tax | $8.9M | -38.4% |
| Net Income | -$182.4M | -1012.4% |
| EPS (Basic) | -$1.84 | -1020.0% |
| EPS (Diluted) | -$1.84 | -1122.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $51.0M | -42.8% |
| Accounts Receivable | $92.9M | -56.0% |
| Current Assets | $152.4M | -49.9% |
| Total Assets | $217.1M | -52.4% |
| Current Liabilities | $67.5M | -44.6% |
| Long-term Debt | $236K | +1228.7% |
| Total Liabilities | $91.2M | -35.0% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $34.5M | -51.0% |
| Capital Expenditures | $4.5M | +18.5% |
| Investing Cash Flow | -$39.1M | -259.5% |
| Financing Cash Flow | -$50.8M | -110.4% |
| Free Cash Flow | $29.9M | -55.0% |
| $144.0M |
| -55.1% |